Shawn W. Semones joins NewLeaf Symbiotics as CTO

Shawn W. Semones, Ph.D., has joined NewLeaf Symbiotics as Chief Technology Officer (CTO). In his new role, Semones will be responsible for driving the company’s technology strategy and growth.

Semones brings extensive experience in agriculture and biotech fields, along with a deep background in established and start-up biotech companies. He is a visionary leader with a proven track record of building profitable growth platforms, developing motivated, high-performing teams and establishing partnerships leading to rapid development and deployment of technologies.

Prior to joining NewLeaf Symbiotics, Semones served as Chief Technology Officer at Anuvia Plant Nutrients. He has also served as Executive Vice President of Research & Development / Chief Technology Officer at Concentric Ag Corporation, where he significantly increased the company's enterprise value. Additionally, Semones held various leadership positions at Novozymes Biologicals Inc. for over 18 years, including Director of BioAg R&D Application Development and Biologicals Site President.

“We are excited to welcome Shawn to NewLeaf Symbiotics as our CTO,” said President Brent Smith. “His deep knowledge of the agriculture and biotech industries, as well as his proven leadership skills, will be instrumental in accelerating our growth and driving our technology strategy forward. We are confident that he will help us continue to enhance our position as a reference in the biologicals industry.”

“I am thrilled to join NewLeaf Symbiotics and to work alongside such a talented team,” said Semones. “The company has a great track record of innovation, and I look forward to working with them to develop new and innovative solutions that will transform the way we think about agriculture and sustainability.”

For more information:
NewLeaf Symbiotics

Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.